Activity
1 event
- Launch21 Aug 2026EUR 128.2M
Alvotech has entered a partnership with Lotus Pharmaceutical to market two biosimilars in the U.S. and Asia, potentially generating up to $150 million in licensing revenue.
▸Source: Viðskiptablaðið
“„Í fyrsta sinn munum við markaðssetja sjálf lyf þróuð af Alvotech í Bandaríkjunum,” segir forstjóri Alvotech.”
People
1 person
Lisa Graver
CEO
The newsletter
One issue a week. Tuesday at 06:00 CET.
Funding rounds, exits, hires, and launches from eight Nordic and Baltic countries. Read in under five minutes, with one editor’s judgement on every issue.
No ads · No algorithmic feed · Free